Title Page Quality Mo Samimi, Ph.D. CMQ/OE Presented at the ASQ Biomedical Division Northern California Discussion Group. May 2011.

Slides:



Advertisements
Similar presentations
Purpose & Values Purpose:
Advertisements

QA Programs for Local Health Departments
History of FDA and Related Regulatory Agencies
Government Agencies HUM-FNW-3 Unit 4. USDA United States Department of Agriculture Mission Statement We provide leadership on food, agriculture, natural.
Public and Private Interests in Animal Research LAT Chapter 1.
What’s New in the FDA’s Pharmaceutical Inspectorate and Risk Based Systems Inspection Rick Perlman Chair Food, Drug, and Cosmetic Division ASQ.
Introduction to Regulation
Becker Grand Rounds: Wally Pellerite June 30, 2011.
Center for Biologics Evaluation and Research Applying Regulatory Science to Advance Development of Innovative, Safe and Effective Biologic Products Carolyn.
Developing a Quality Management System Viki Massey Quality Coordinator A Joint Venture of London Health Sciences Centre and St. Joseph’s Health Care London.
Bibliographic Instruction Presentation (LIS 5916) U.S. Food and Drug Administration (FDA) By George Nichols (June 2005)
FDA’s Pharmaceutical Inspectorate Robert Coleman National Expert Drug Investigator Food and Drug Administration.
Five-Level Performance Management System. Caveat for Bargaining Unit Employees The following presentation is intended for: – Non-bargaining unit employees.
The FDA Landscape AdvaMed September 2008 Judith K. Meritz
4. Quality Management System (QMS)
FDA Resources and Meetings FDA/EMA Orphan Designation and Grant Workshop Silver Spring, Maryland FDA Campus (White Oak) October 12, 2012 Bill Sutton Deputy.
JENN SHAFNER BRIAN KROUSE CLINT KEHRES. Pre ISO 9000  The BS 5750 standard required factories to document manufacturing procedures.  BS 5750 was known.
FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement.
The Changing Food Environment The Role and Activities of the U.S. Food and Drug Administration Transatlantic Consumer Dialogue The Changing Food Environment.
WHAT IS ISO 9000.
How get your project management or professional services organization ISO 9001 certified.
Regulatory Overview.
Ashland Specialty Ingredients IFAC’s cGMP Audit Guide How the Food Ingredient Industry has Responded to FSMA and Food Safety Audits Priscilla Zawislak.
Center for Veterinary Medicine (CVM) RECALLS.  21 CFR 7.40 provides guidance on the policy, procedures, and industry responsibilities for recalls. 
Postgraduate Educational Course in radiation protection and the Safety of Radiation sources PGEC Part IV The International System of Radiation Protection.
FDA Regulatory review in Minutes: What Product Development Executives Need-to-Know. Specifically, frequent causes of recalls and related areas that investigators.
Patient Safety and Medical Devices Sonia Swayze, RN, MA, C and Suzanne Rich, RN, MA, CT.
FDA, PDUFA AND MEDICAL INNOVATION Spring WHAT IS THE FOOD AND DRUG ADMINISTRATION (FDA)? The FDA is an agency within the U.S. Department of Health.
Lec#3 Project Quality Management Ghazala Amin. 2 Quality Specialist-Job responsibility Responsibilities Reports monitoring and measurement of processes.
The Blue Mountain Summit 2012 Top FDA Enforcement Trends What You Need to Know about FDA’s Latest Priorities and Initiatives By: Martin Browning, EduQuest,
Introduction to ISO 9001:2000.
September 22, 2015 NOAA’s Seafood Safety and Quality Programs: Meeting the Challenges of a Global Seafood Supply.
REGULATORY CHALLENGES FOR NANOMATERIALS IN PUBLIC HEALTH Driving Faster Than Our Nano-Headlights AAAS Annual Meeting February 13, 2009 Norris E. Alderson,
Counter-terrorism at FDA Andrea Meyerhoff MD Director, Office of Counter-terrorism US Food and Drug Administration.
Regulatory Big Brother of Biotechnology. Role of FDA FDA was designed to promote and protect the public’s health Food and Drug Cosmetic Act first passed.
FDA’s Perspective on the “Pharmaceutical cGMPs for the 21st Century” Initiative David J. Horowitz, Esq. Director, CDER/FDA, Office of Compliance Advisory.
PATRICIA KERBY, MPA HUMAN SUBJECTIONS PROTECTION COMPLIANCE OFFICER OFFICE OF RESEARCH COMPLIANCE What are the FDA’s expectations in 2010?
Research Peer-Review at CDER Past and Present Jerry M. Collins, Ph.D. Director, Laboratory of Clinical Pharmacology, OTR Acting Director, Division of Applied.
Center for Biologics Evaluation and Research Carolyn A. Wilson, Ph.D. Associate Director for Research Applying Regulatory Science to Advance Development.
1 Implementing a Business Management System compliant to ISO 9001:2000.
Geoffrey L. Beausoleil Assistant Manager, Office of Operational Support DOE Idaho Operations Office September 12, 2006 Presentation to DOE ISM Champions.
Module C FDA Regulations Regulatory Documents Patricia E. Koziol 1Module C Final Version 10-apr-2010.
Component 1: Introduction to Health Care and Public Health in the U.S. 1.1: Unit 2: Health Care Settings 1.2 a: Overview and the Organization of Federal.
Nanotechnology - USDA - 18 Nov 2002 REGULATORY CONSIDERATIONS FOR NANOTECHNOLOGY IN PUBLIC HEALTH FOOD AND DRUG ADMINISTRATION Norris E. Alderson, Ph.D.
Progress in FDA’s Drug Product Quality Initiative Janet Woodcock, M.D. November 13, 2003.
The Second Annual Medical Device Regulatory, Reimbursement and Compliance Congress Presented by J. Glenn George Thursday, March 29, 2007 Day II – Track.
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
FDA job description  Regulates about 25% of all consumer purchases  Mission summary: protect and advance public health  Products: food, cosmetics, drugs,
Research in the Office of Cellular, Tissue and Gene Therapies: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation.
1 Estimating CDER Resources Devoted to Safety Theresa M. Mullin, Ph.D. Office of Planning, Office of Commissioner April 15, 2005 Presentation to: FDA Science.
FDA Risk Communication Nancy M. Ostrove, PhD Senior Advisor for Risk Communication Risk Communication Advisory Committee February 28, 2008.
Alex Ezrakhovich Process Approach for an Integrated Management System Change driven.
1 QUALITY MANAGEMENT SYSTEM PRESENTATION TO BOTSWANA DRUG ADVISORY BOARD MEMBERS 13 th – 17 th AUGUST 2007.
Hospital Accreditation Documentation Process & Standard Requirements
Good Manufacturing Practices
ROLES AND RESPONSIBILITIES OF TFDA ON ADDO PROGRAM
Quality Management.
My Experiences as an FDA Statistician
נמטוציטים משושנת ים Eli. S Lec. No.2.
Case Studies in Big Data and Analysis
FDA Perspective on Cardiovascular Device Development
CDRH 2010 Strategic Priorities
Five-Level Performance Management System
American Society for Quality Region 5 Quality Conference
Overview of ISO 9001:2015 –Quality Management SysteM
INTRODUCTION TO ISO 9001:2015 FOR IMPLEMENTATION Varinder Kumar CISA, ISO27001 LA, ISO 9001 LA, ITIL, CEH, MEPGP IT, Certificate course in PII & Privacy.
Overview of FDA Food Inspections
Lockheed Martin Canada’s SMB Mentoring Program
Visualization Using Open-Source Tools: some FDA perspectives
Presentation transcript:

Title Page Quality Mo Samimi, Ph.D. CMQ/OE Presented at the ASQ Biomedical Division Northern California Discussion Group. May 2011

A short personal history Finished Ph.D. in Food Science in ’84, and worked as a Post-Doc for 2 years Worked in the Food Industry for 7 years Consulting for 9 years Joined FDA in 2003 –QSM in SAN-DO Lab for ISO accreditation. –Joined the QMS group in the Office of the ACRA in 2009.

Looking from the outside

Looking from the inside

FDA ORG Chart

FDA Organization Charts FDA Organization Charts Centers & Offices Centers & Offices –Office of the Commissioner –Center for Biologics Evaluation and Research (CBER) –Center for Devices and Radiological Health (CDRH) –Center for Drug Evaluation and Research (CDER) –Center for Food Safety and Applied Nutrition (CFSAN) –Center for Tobacco Products (CTP) (New) –Center for Veterinary Medicine (CVM) –National Center for Toxicological Research (NCTR) –Office of Regulatory Affairs (ORA)

How do you implement QMS? How do you implement QMS in a bureaucratic –and compartmented- organization? How do you align QMS with the FDA’s mission and vision?

How does a large organization, such as the FDA, accomplish it’s mission? Alignment in purpose for all its functional units.

FDA Mission FDA is charged with protecting the public health by ensuring the safety, effectiveness, and security of human and veterinary drugs, biological products, and medical devices; ensuring the safety of foods, cosmetics, and radiation-emitting products; and regulating tobacco products. Specifically, FDA is responsible for advancing the public health by: Helping to speed innovations that make foods safer and make medicines and devices safer and more effective; Ensuring the public has accurate, science-based information they need to use medicines, devices, and foods to improve their health; Regulating the manufacture, marketing, and distribution of tobacco products and reducing tobacco use by minors; and, Addressing the Nation’s counterterrorism capability and ensuring the security of the supply of foods and medical products.

FDA Vision FDA is dedicated to world-class excellence as a science-based regulatory agency with a public health mission. We aim to provide effective and innovative leadership — both domestically and internationally — to protect health, prevent illness, prolong life, and promote wellness.

The mission of HHS is to enhance the health and well-being of Americans by providing effective health and human services and by fostering sound, sustained advances in the sciences needed to promote medicine, public health, and social services. HHS Mission

ORA Mission and Vission ORA Vision: All food is safe; all medical products are safe and effective; and the public health is protected and advanced. ORA Mission: Protecting consumers and enhancing public health by maximizing compliance of FDA regulated products and minimizing risk associated with those products.

What QMS hopes to achieve Supervisors Employees Management Mandate and Funding (Congress)

Staff Manual Guide (SMG) 2020 Similar to the International Standards (ISO, etc.), SMG defines the requirements, and establishes guidelines, to allow each Center or Office, to set up their own QMS.

SMG2020 Page

QMS at FDA today

Strategic Priorities

FDA Strategic Priorities

QM Plan FOREWORD Quality is defined as a measure of a product's or service's ability to satisfy the customer's stated or implied needs (Staff Manual Guide (SMG) 2020). Quality Systems (also called Quality Management Systems) are formalized business practices that define management responsibilities for organizational structure, processes, procedures, and resources needed to fulfill product/service requirements, customer satisfaction, and continual improvement (SMG 2020). There are many quality process improvement models that take this approach, including the plan– do–check–act cycle included in SMG Quality Systems are typically documented and managed by means of Quality Management Plans (QMPs).

CDRH – Direct Reports

CFSAN QA Newsletter

CFSAN Lab QM

ORA-Timeline1

ORA-Timeline2

ORA-Timeline3

ORA-Timeline4

ORA Quality Policy

ORA QM

ORA Core QMS Procedures ORA-QMS.001 Document Control & Management ORA-QMS.002 Record Control ORA-QMS.003 Management Review ORA-QMS.004 Audits ORA-QMS.005 Control of Non-Conforming Processes, Services or Products ORA-QMS.006 Continual Improvement Procedure ORA-QMS.007 Corrective Action Procedures ORA-QMS.008 Preventive Action Procedure ORA-QMS.009 Complaints and Other Feedback

Current State of ORA All ORA units have at least one QSM All units of ORA have implemented the core procedures. At least one round of management review is conducted in each business unit. All QSMs will be ASQ certified (CMQ/OE) by the mid FY Audits performed on all units for basic quality functions (e.g. doc control, records management, etc.)

Application of QMS at FDA Documented QMS reviews by the Management. Records of non-conformances for trending and process improvement Addressing internal/external* complaints, and starting corrective actions when needed. Opening proper communications channels between different “pyramids” within the FDA. Making sure the Management takes ownership of quality issues.

Inventory Approximate Numbers Inventory Approximate Numbers (not including medical gas) USA 2,000 human drug manufacturing sites 1,100 human drug CGMP inspections/yr 200 pre-market approval inspections 200 pre-market approval inspectionsInternational 3,500 human drug manufacturing sites 200 human drug quality inspections/yr 200 human drug quality inspections/yr

FDA’s Foreign Inspection Accomplishments

Why QMS is important to the FDA?

Thank you! Links and info – – and